Age Related Macular Degeneration Drug Market Status and Forecast in Global by Product Type and End-user and Regions(Countries) 2016-2026 (COVID-19 Version)

SKU ID :99ST-18265720 | Published Date: 16-May-2021 | No. of pages: 97
TABLE OF CONTENTS 1 INDUSTRY OVERVIEW 1.1 Age Related Macular Degeneration Drug Industry 1.1.1 Age Related Macular Degeneration Drug Overview 1.1.2 Terminology Definition in the Report 1.1.2.1 Capacity 1.1.2.2 Sales Volume 1.1.2.3 Sales Revenue 1.1.2.4 Ex-factory Price & Sales Price 1.1.2.5 Cost 1.1.2.6 Gross Margin 1.2 Products & Services Overview Scope 1.3 Age Related Macular Degeneration Drug in the Industry Chain 1.4 Industry Dynamics & Regulations 1.5 Global Market Overview 2 UPSTREAM & MANUFACTURING 2.1 Raw Materials / Components 2.2 Procurement Methods & Channels 2.3 Cost Structure & Manufacturing 2.4 Industry Capacity Overview 2.5 Production Distribution by Geography 2.5.1 Production in Major Regions / Countries 2.5.2 Trade Flow Overview 3 PRODUCT SEGMENT 3.1 Product Segmentation Market (2017 to 2021E) 3.1.1 Lucentis Market 3.1.2 Eylea Market 3.1.3 Avastin Market 3.1.4 Other Market 3.2 Market Status 4 APPLICATION / END-USE SEGMENT 4.1 Application Segmentation Market (2016 to 2021E) 4.1.1 Hospitals Market 4.1.2 Clinics Market 4.1.3 Other Market 4.2 Market Status 5 NORTH AMERICA 5.1 North America Market Growth 5.2 North America Market by Countries 5.3 Major Countries Market Growth 5.3.1 United States Market Size and Growth (2016-2021E) 5.3.2 Canada Market Size and Growth (2016-2021E) 5.3.3 Mexico Market Size and Growth (2016-2021E) 6 EUROPE 6.1 Europe Market Growth 6.2 Europe Market by Countries 6.3 Major Countries Market Growth 6.3.1 Germany Market Size and Growth (2016-2021E) 6.3.2 UK Market Size and Growth (2016-2021E) 6.3.3 France Market Size and Growth (2016-2021E) 6.3.4 Russia Market Size and Growth (2016-2021E) 6.3.5 Italy Market Size and Growth (2016-2021E) 6.3.6 Rest of Europe Market Size and Growth (2016-2021E) 7 ASIA-PACIFIC 7.1 ASIA-PACIFIC Market Growth 7.2 ASIA-PACIFIC Market by Countries 7.3 Major Countries Market Growth 7.3.1 China Market Size and Growth (2016-2021E) 7.3.2 India Market Size and Growth (2016-2021E) 7.3.3 Japan Market Size and Growth (2016-2021E) 7.3.4 South Korea Market Size and Growth (2016-2021E) 7.3.5 Southeast Asia Market Size and Growth (2016-2021E) 7.3.6 Australia Market Size and Growth (2016-2021E) 7.3.7 Rest of Asia Pacific Market Size and Growth (2016-2021E) 8 SOUTH AMERICA 8.1 South America Market Growth 8.2 South America Market by Countries 8.3 Major Countries Market Growth 8.3.1 Brazil Market Size and Growth (2016-2021E) 8.3.2 Argentina Market Size and Growth (2016-2021E) 8.3.3 Rest of South America Market Size and Growth (2016-2021E) 9 MIDDLE EAST & AFRICA 9.1 Middle East and Africa Market Growth 9.2 Middle East and Africa Market by Countries 9.3 Major Countries Market Growth 9.3.1 GCC Market Size and Growth (2016-2021E) 9.3.2 North Africa Market Size and Growth (2016-2021E) 9.3.3 South Africa Market Size and Growth (2016-2021E) 9.3.4 Rest of Middle East & Africa Market Size and Growth (2016-2021E) 10 MARKET FORECAST 10.1 Global Market Forecast Overview 10.2 Global Market Forecast by Type 10.3 Global Market Forecast by Application / End-Use 10.4 Global Market Forecast by Region 11 COMPETITION OF MAJOR PLAYERS 11.1 Regeneron Pharmaceuticals (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.1.1 Regeneron Pharmaceuticals Profile 11.1.2 Regeneron Pharmaceuticals Products & Services Overview 11.1.3 Regeneron Pharmaceuticals Main Business 11.1.4 Regeneron Pharmaceuticals Business Operation 11.2 Bayer HealthCare (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.2.1 Bayer HealthCare Profile 11.2.2 Bayer HealthCare Products & Services 11.2.3 Bayer HealthCare Main Business 11.2.4 Bayer HealthCare Business Operation 11.3 Novartis (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.3.1 Novartis Profile 11.3.2 Novartis Products & Services 11.3.3 Novartis Main Business 11.3.4 Novartis Business Operation 11.4 Roche (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.4.1 Roche Profile 11.4.2 Roche Products & Services 11.4.3 Roche Main Business 11.4.4 Roche Business Operation 11.5 Kanghong Pharma (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.5.1 Kanghong Pharma Profile 11.5.2 Kanghong Pharma Products & Services 11.5.3 Kanghong Pharma Main Business 11.5.4 Kanghong Pharma Business Operation 12 COMPANY COMPETITION 12.1 Global Sales by Company 12.1.1 Global Sales by Company 12.1.2 Global Sales Share by Company 12.2 Price & Gross Margin 12.3 Landscape of Major Companies in the Market 12.3.1 Major Companies Product Type List 12.3.1 Manufacturing Regions and Headquarters of Major Companies 12.3.1 Mergers & Acquisitions 12.4 Competitive Environment for New Entrants 12.4.1 Michael Porter's Five Forces Model 12.4.2 SWOT 13 ENVIRONMENT OVERVIEW 13.1 Impact of COVID-19 13.2 Geopolitics Overview 13.3 Economic Overview of Major Countries 14 RESEARCH CONCLUSION
LIST OF TABLE TABLE ~ Age Related Macular Degeneration Drug Industry Dynamics & Regulations List TABLE ~ Global Age Related Macular Degeneration Drug Sales Volume, Revenue, Price, Cost and Margin, 2016-2021E TABLE ~ Lucentis Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Lucentis Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Eylea Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Eylea Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Avastin Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Avastin Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Other Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Other Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global Age Related Macular Degeneration Drug Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global Age Related Macular Degeneration Drug Market Size by Type, 2016-2021E, in Volume TABLE ~ Hospitals Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Hospitals Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Clinics Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Clinics Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Other Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Other Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global Age Related Macular Degeneration Drug Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global Age Related Macular Degeneration Drug Market Size by Type, 2016-2021E, in Volume TABLE ~ North America Age Related Macular Degeneration Drug Sales by Countries 2016-2021E, in USD Million TABLE ~ North America Age Related Macular Degeneration Drug Sales Share by Countries 2016-2021E, in USD Million TABLE ~ North America Age Related Macular Degeneration Drug Sales by Countries 2016-2021E, in Volume TABLE ~ North America Age Related Macular Degeneration Drug Sales Share by Countries 2016-2021E, in Volume TABLE ~ United States Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Canada Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Mexico Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Europe Age Related Macular Degeneration Drug Sales by Countries 2016-2021E, in USD Million TABLE ~ Europe Age Related Macular Degeneration Drug Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Europe Age Related Macular Degeneration Drug Sales by Countries 2016-2021E, in Volume TABLE ~ Europe Age Related Macular Degeneration Drug Sales Share by Countries 2016-2021E, in Volume TABLE ~ Germany Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ UK Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ France Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Russia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Italy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Europe Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ ASIA-PACIFIC Age Related Macular Degeneration Drug Sales by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC Age Related Macular Degeneration Drug Sales Share by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC Age Related Macular Degeneration Drug Sales by Countries 2016-2021E, in Volume TABLE ~ ASIA-PACIFIC Age Related Macular Degeneration Drug Sales Share by Countries 2016-2021E, in Volume TABLE ~ China Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ India Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Japan Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Korea Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Southeast Asia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Australia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Asia Pacific Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South America Age Related Macular Degeneration Drug Sales by Countries 2016-2021E, in USD Million TABLE ~ South America Age Related Macular Degeneration Drug Sales Share by Countries 2016-2021E, in USD Million TABLE ~ South America Age Related Macular Degeneration Drug Sales by Countries 2016-2021E, in Volume TABLE ~ South America Age Related Macular Degeneration Drug Sales Share by Countries 2016-2021E, in Volume TABLE ~ Brazil Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Argentina Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of South America Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Middle East and Africa Age Related Macular Degeneration Drug Sales by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa Age Related Macular Degeneration Drug Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa Age Related Macular Degeneration Drug Sales by Countries 2016-2021E, in Volume TABLE ~ Middle East and Africa Age Related Macular Degeneration Drug Sales Share by Countries 2016-2021E, in Volume TABLE ~ GCC Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ North Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Middle East & Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Global Age Related Macular Degeneration Drug Sales Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global Age Related Macular Degeneration Drug Sales Share Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global Age Related Macular Degeneration Drug Sales Forecast by Type 2022F-2026F, in Volume TABLE ~ Global Age Related Macular Degeneration Drug Sales Share Forecast by Type 2022F-2026F, in Volume TABLE ~ Global Age Related Macular Degeneration Drug Sales Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global Age Related Macular Degeneration Drug Sales Share Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global Age Related Macular Degeneration Drug Sales Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global Age Related Macular Degeneration Drug Sales Share Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global Age Related Macular Degeneration Drug Sales Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global Age Related Macular Degeneration Drug Sales Share Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global Age Related Macular Degeneration Drug Sales Forecast by Region 2022F-2026F, in Volume TABLE ~ Global Age Related Macular Degeneration Drug Sales Share Forecast by Region 2022F-2026F, in Volume TABLE ~ Regeneron Pharmaceuticals Overview List TABLE ~ Products & Services List of Regeneron Pharmaceuticals TABLE ~ Business Operation of Regeneron Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Bayer HealthCare Overview List TABLE ~ Products & Services List of Bayer HealthCare TABLE ~ Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Novartis Overview List TABLE ~ Products & Services List of Novartis TABLE ~ Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Roche Overview List TABLE ~ Products & Services List of Roche TABLE ~ Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Kanghong Pharma Overview List TABLE ~ Products & Services List of Kanghong Pharma TABLE ~ Business Operation of Kanghong Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Global Age Related Macular Degeneration Drug Sales by Company 2016-2021E, in USD Million TABLE ~ Global Age Related Macular Degeneration Drug Sales by Company 2016-2021E, in Volume TABLE ~ Global Age Related Macular Degeneration Drug Sales Share by Company 2016-2021E, in USD Million TABLE ~ Global Age Related Macular Degeneration Drug Sales Share by Company 2016-2021E, in Volume TABLE ~ Global Age Related Macular Degeneration Drug Sales Price by Company 2016-2021E, in USD/Volume TABLE ~ Global Age Related Macular Degeneration Drug Gross Margin by Company 2016-2021E TABLE ~ Major Companies Product Type List TABLE ~ Major Companies Product Type List TABLE ~ Mergers & Acquisitions in the Market
  • PRICE
  • $3250
    $6500
    Buy Now

Our Clients